Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.07
GTIV's Cash to Debt is ranked higher than
52% of the 230 Companies
in the Global Medical Care industry.

( Industry Median: 0.28 vs. GTIV: 0.07 )
GTIV' s 10-Year Cash to Debt Range
Min: 0.01   Max: No Debt
Current: 0.07

Equity to Asset -0.24
GTIV's Equity to Asset is ranked lower than
56% of the 231 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. GTIV: -0.24 )
GTIV' s 10-Year Equity to Asset Range
Min: -0.24   Max: 0.73
Current: -0.24

-0.24
0.73
F-Score: 3
Z-Score: -1.23
M-Score: -4.84
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) -30.56
GTIV's Operating margin (%) is ranked lower than
56% of the 233 Companies
in the Global Medical Care industry.

( Industry Median: 9.44 vs. GTIV: -30.56 )
GTIV' s 10-Year Operating margin (%) Range
Min: -30.56   Max: 9.38
Current: -30.56

-30.56
9.38
Net-margin (%) -34.69
GTIV's Net-margin (%) is ranked lower than
55% of the 233 Companies
in the Global Medical Care industry.

( Industry Median: 5.38 vs. GTIV: -34.69 )
GTIV' s 10-Year Net-margin (%) Range
Min: -34.69   Max: 12.38
Current: -34.69

-34.69
12.38
ROA (%) -47.44
GTIV's ROA (%) is ranked lower than
56% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 3.98 vs. GTIV: -47.44 )
GTIV' s 10-Year ROA (%) Range
Min: -47.44   Max: 16.57
Current: -47.44

-47.44
16.57
ROC (Joel Greenblatt) (%) -517.17
GTIV's ROC (Joel Greenblatt) (%) is ranked lower than
57% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 17.97 vs. GTIV: -517.17 )
GTIV' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -517.17   Max: 160.46
Current: -517.17

-517.17
160.46
Revenue Growth (%) 5.20
GTIV's Revenue Growth (%) is ranked higher than
70% of the 180 Companies
in the Global Medical Care industry.

( Industry Median: 7.20 vs. GTIV: 5.20 )
GTIV' s 10-Year Revenue Growth (%) Range
Min: -26.3   Max: 13
Current: 5.2

-26.3
13
» GTIV's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2013

GTIV Guru Trades in Q1 2013

David Dreman 487,716 sh (New)
Joel Greenblatt 187,403 sh (+273.1%)
Jim Simons 334,516 sh (+38.39%)
Mario Gabelli 818,900 sh (+34.03%)
Chuck Royce 23,000 sh (unchged)
» More
Q2 2013

GTIV Guru Trades in Q2 2013

Joel Greenblatt 230,677 sh (+23.09%)
Mario Gabelli 928,700 sh (+13.41%)
Chuck Royce 23,000 sh (unchged)
David Dreman 412,743 sh (-15.37%)
Jim Simons 197,916 sh (-40.84%)
» More
Q3 2013

GTIV Guru Trades in Q3 2013

Mario Gabelli 972,200 sh (+4.68%)
Chuck Royce 23,000 sh (unchged)
Joel Greenblatt 193,536 sh (-16.1%)
Jim Simons 150,516 sh (-23.95%)
David Dreman 117,669 sh (-71.49%)
» More
Q4 2013

GTIV Guru Trades in Q4 2013

Paul Tudor Jones 13,200 sh (New)
Jim Simons 174,216 sh (+15.75%)
David Dreman 134,335 sh (+14.16%)
Joel Greenblatt 198,153 sh (+2.39%)
Mario Gabelli 977,200 sh (+0.51%)
Chuck Royce 23,000 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with GTIV

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
David Dreman 2013-09-30 Reduce -71.49%0.11%$8.6 - $13.73 $ 7.72-32%117669
Joel Greenblatt 2013-06-30 Add 23.09%0.02%$9.32 - $11.77 $ 7.72-26%230677
David Dreman 2013-03-31 New Buy0.14%$9.44 - $12.62 $ 7.72-29%487716
Joel Greenblatt 2013-03-31 Add 273.1%0.07%$9.44 - $12.62 $ 7.72-29%187403
Mario Gabelli 2013-03-31 Add 34.03%0.01%$9.44 - $12.62 $ 7.72-29%818900
Joel Greenblatt 2012-12-31 Reduce -25.46%0.01%$9.37 - $11.36 $ 7.72-24%50229
Joel Greenblatt 2012-09-30 New Buy0.05%$6.11 - $12.57 $ 7.72-17%67382
Mario Gabelli 2012-03-31 Add 77.53%0.02%$6.45 - $8.83 $ 7.728%640000
Joel Greenblatt 2011-12-31 Sold Out 0.03%$3.02 - $7.18 $ 7.7254%0
Joel Greenblatt 2011-09-30 Add 152.07%0.02%$5.3 - $21.05 $ 7.72-32%34609
Mario Gabelli 2011-09-30 Add 26.78%$5.3 - $21.05 $ 7.72-32%350300
Joel Greenblatt 2011-06-30 New Buy0.04%$19.41 - $28.57 $ 7.72-68%13730
Mario Gabelli 2011-06-30 Add 139.22%0.02%$19.41 - $28.57 $ 7.72-68%276300
Mario Gabelli 2011-03-31 Add 1343.75%0.02%$23.02 - $28.9 $ 7.72-71%115500
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about Gentiva Health Services, Inc.

Gabelli Increases Holdings in Struggling Gentiva Health Services
Mario Gabelli increased his holdings in Gentiva Health Services (GTIV) by 8.96% on June 13. Gabelli purchased a total of 73,400 shares at an average price of $11.50 per share. Since this transaction, the price per share has decreased approximately 10% and is currently trading around $10.39 per share. Gabelli now owns 892,300 shares of Gentiva, representing approximately 3.1% of the company’s shares outstanding. Gabelli’s holding history of Gentiva as of March 31: Read more...

Ratios

vs
industry
vs
history
P/S 0.14
GTIV's P/S is ranked higher than
100% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 1.37 vs. GTIV: 0.14 )
GTIV' s 10-Year P/S Range
Min: 0.06   Max: 0.77
Current: 0.14

0.06
0.77
PFCF 15.20
GTIV's PFCF is ranked higher than
66% of the 165 Companies
in the Global Medical Care industry.

( Industry Median: 15.52 vs. GTIV: 15.20 )
GTIV' s 10-Year PFCF Range
Min: 2.1   Max: 62.17
Current: 15.2

2.1
62.17
EV-to-EBIT 5.90
GTIV's EV-to-EBIT is ranked higher than
99% of the 205 Companies
in the Global Medical Care industry.

( Industry Median: 17.82 vs. GTIV: 5.90 )
GTIV' s 10-Year EV-to-EBIT Range
Min: 5.7   Max: 27.3
Current: 5.9

5.7
27.3

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 1.00
GTIV's Price/DCF (Projected) is ranked higher than
75% of the 122 Companies
in the Global Medical Care industry.

( Industry Median: 1.10 vs. GTIV: 1.00 )
GTIV' s 10-Year Price/DCF (Projected) Range
Min: 0.31   Max: 1.61
Current: 1

0.31
1.61
Price/Median PS Value 0.30
GTIV's Price/Median PS Value is ranked higher than
97% of the 206 Companies
in the Global Medical Care industry.

( Industry Median: 1.10 vs. GTIV: 0.30 )
GTIV' s 10-Year Price/Median PS Value Range
Min: 0.2   Max: 1.49
Current: 0.3

0.2
1.49
Earnings Yield (Greenblatt) 17.00
GTIV's Earnings Yield (Greenblatt) is ranked higher than
98% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 5.50 vs. GTIV: 17.00 )
GTIV' s 10-Year Earnings Yield (Greenblatt) Range
Min: 3.7   Max: 17.5
Current: 17

3.7
17.5
Forward Rate of Return (Yacktman) 24.09
GTIV's Forward Rate of Return (Yacktman) is ranked higher than
89% of the 169 Companies
in the Global Medical Care industry.

( Industry Median: 11.19 vs. GTIV: 24.09 )
GTIV' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 2.7   Max: 59.9
Current: 24.09

2.7
59.9

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:GHT.Germany
Gentiva Health Services, Inc., is a provider of home health services & hospice services serving patients throughout the United States. The Company provides a single source for skilled nursing; physical, occupational, speech and neurorehabilitation services; hospice services; social work; nutrition; disease management education; help with daily living activities; and other therapies and services. The Company's operations involve servicing patients and customers through its Home Health segment and Hospice segment. The Home Health segment is comprised of direct home nursing and therapy services operations, including specialty programs and its consulting business. The Company conducts direct home nursing and therapy services operations through licensed and Medicare-certified agencies from which the Company provides various combinations of skilled nursing and therapy services and paraprofessional nursing services to adult and elder patients. Reimbursement sources primarily include government programs, such as Medicare and Medicaid, and private sources, such as health insurance plans, managed care organizations, long term care insurance plans and personal funds. The Company's Hospice segment serves terminally ill patients and their families through more than 165 locations operating in 30 states. Depending on a patient's needs, each hospice patient is assigned an interdisciplinary team comprised of a physician, nurse(s), home health aide(s), medical social worker(s), chaplain, dietary counselor and bereavement coordinator, as well as other care professionals. Hospice services are provided primarily in the patient's home or other residence, such as an assisted living residence or nursing home, or in a hospital. The Medicare hospice benefit is designed for patients expected to live six months or less. Hospice services for a patient can continue, however, for more than six months, so long as the patient remains eligible as reflected by a physician's certification. The Company's home health and hospice businesses obtain patients and clients through personal and corporate sales presentations, telephone marketing calls, direct mail solicitation, referrals from other clients and advertising in a variety of local and national media, including the Yellow Pages, newspapers, magazines, trade publications and radio. The home health services industry in which the Company operates is highly competitive and fragmented. The Company's primary competitors for its home healthcare business are hospital-based home health agencies, local home health agencies and visiting nurse associations. The Company's business is subject to extensive federal, state and, in some instances, local regulations and standards which govern Medicare, Medicaid, TRICARE and other government-funded reimbursement programs.

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide